| Issue Date | Title | Involved Person(s) |
| 14-Feb-2024 | Suicide rates and prescription of antidepressants | Amendola, Simone; Plöderl, Martin; Hengartner, Michael Pascal |
| 2024 | Suicidality emerging from rapid Venlafaxine discontinuation | Kostic, Milutin; Plöderl, Martin; Hengartner, Michael; Buzejic, Jelena |
| 2024 | Beneficial and harmful effects of tricyclic antidepressants for adults with major depressive disorder : a systematic review with meta-analysis and trial sequential analysis | Kamp, Caroline Barkholt; Petersen, Johanne Juul; Faltermeier, Pascal; Juul, Sophie; Siddiqui, Faiza, et al |
| 2-Dec-2023 | Wirksamkeitsforschung heute : das Beispiel Depressionsbehandlungen | Hengartner, Michael Pascal |
| 15-Nov-2023 | Antidepressants use in Italy : an ecological study of national and regional trends and associated factors | Amendola, Simone; Hengartner, Michael Pascal |
| 5-Sep-2023 | Prevalence, trends, and individual patterns of long-term antidepressant medication use in the adult Swiss general population | Amrein, Melanie A.; Hengartner, Michael P.; Näpflin, Markus; Farcher, Renato; Huber, Carola A. |
| Sep-2023 | Re: "A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder" by Strawn et al. : concerning harm-benefit ratio in a recent trial about Escitalopram for generalized anxiety disorder | Plöderl, Martin; Horowitz, Mark A.; Hengartner, Michael P. |
| 30-Mar-2023 | The risks of adverse events with venlafaxine and mirtazapine versus 'active placebo', placebo, or no intervention for adults with major depressive disorder : a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis | Jørgensen, Caroline Kamp; Juul, Sophie; Siddiqui, Faiza; Horowitz, Mark Abie; Moncrieff, Joanna, et al |
| 14-Dec-2022 | Estimating risk of antidepressant withdrawal from a review of published data | Horowitz, Mark Abie; Framer, Adele; Hengartner, Michael P.; Sørensen, Anders; Taylor, David |
| 14-Feb-2022 | Opinion: Regulators are approving drugs without clear evidence that they work | Hengartner, Michael Pascal |
| 2022 | Suizidpräventive Effekte von Ketamin und Esketamin | Plöderl, Martin; Hengartner, Michael P.; Volkmann, Constantin |
| 17-Dec-2021 | Effect of the FDA black box suicidality warnings for antidepressants on suicide rates in the USA : signal or noise? | Plöderl, Martin; Hengartner, Michael Pascal |
| Dec-2021 | Evidence-biased antidepressant prescription : overmedicalisation, flawed research, and conflicts of interest | Hengartner, Michael P. |
| 8-Nov-2021 | Learning about the course of suicidal behavior but not about the effects of SSRIs | Plöderl, Martin; Hengartner, Michael Pascal |
| 2021 | Beneficial and harmful effects of antidepressants versus placebo, ‘active placebo’, or no intervention for adults with major depressive disorder : a protocol for a systematic review of published and unpublished data with meta-analyses and trial sequential analyses | Juul, Sophie; Siddiqui, Faiza; Barbateskovic, Marija; Jørgensen, Caroline Kamp; Hengartner, Michael Pascal, et al |
